Thrombolysis Plus Aortic Counterpulsation: Improved Survival in Patients Who Present to Community Hospitals With Cardiogenic Shock

This publication has 22 references indexed in Scilit:

• Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience
  Journal of the American College of Cardiology, 1995
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
  Published by Elsevier ,1994
• The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator
  Journal of the American College of Cardiology, 1992
• Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock
  Journal of the American College of Cardiology, 1991
• Cardiogenic Shock after Acute Myocardial Infarction
  New England Journal of Medicine, 1991
• In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin
  The Lancet, 1990
• Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction
  Journal of the American College of Cardiology, 1985
• Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure
  The American Journal of Cardiology, 1981